AVTR Avantor, Inc. Common Stock
关于 Avantor, Inc. Common Stock 公司概况(来自维基百科)
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.
阅读更多
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.
History
The company's history traces back to 1904, when John Townsend Baker (1860–1935) founded the chemical company J.T. Baker specializing in producing chemically pure reagents. The company gained recognition for its "Baker Analyzed" labels, which provided detailed analyses of trace impurities in its products. In 1911, the company began publishing "The Chemist-Analyst," which promoted its products and philosophy. After Baker's death in 1935, the company was acquired by Vick Chemical Company in 1941. During World War II, J.T. Baker expanded its product line to include penicillin, pesticides, and chemicals for batteries and munitions. After the war, the company further diversified into high-purity solvents, chromatography columns, and hazardous waste spill kits. In 1985, J.T. Baker and its parent company Richardson-Vicks were sold to Procter & Gamble, and subsequently sold to Mallinckrodt in 1995.
In 2010, investment firm New Mountain Capital purchased Mallinckrodt Baker Inc., which then changed its name to Avantor. The company extended its international market with the 2011 acquisitions of the Indian laboratory reagents supplier RFCL and the Polish lab supply firm POCH.
In 2016, Avantor merged with Nusil Technology. In 2017, Avantor acquired chemical blending business Puritan Products Inc. and laboratory supplies company VWR. The combined company operates under the Avantor name, with VWR and vwr.com remaining as a selling channel.
In May 2019, Avantor went public with a $3.8 billion initial public offering, which gave the company a market capitalization of $7.62 billion. As of December 2023, the top shareholders of Avantor included Vanguard Group Inc., Dodge & Cox Inc., T. Rowe Price Investment Management Inc., and BlackRock Inc.
That same year the company expanded further into Asia with the opening of an innovation center in Shanghai, which focuses on monoclonal antibodies and cell and gene therapy. In 2020, Avantor doubled the size of its Bridgewater, New Jersey innovation center, expanding its research and development capabilities and cell and gene therapy reagent manufacturing.
In 2020, Avantor began providing services and raw materials to companies manufacturing vaccines and other therapies to fight the COVID-19 pandemic. Avantor added employees and extra shifts in order to increase capacity for producing synthetic lipids that are formed into nanoparticles, which carry mRNA into human cells.
In June 2021, Avantor acquired China-based RIM Bio, a manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.
Through the acquisition, Avantor gained access to RIM's Changzhou, China facility, marking Avantor's first single-use production plant in the Africa, Middle East, Asia (AMEA) region. The deal is part of a larger expansion of the company's single-use manufacturing footprint with plans to increase its presence by 30%.
The company ranked 485th in 2023 and 506 in 2024 on the Fortune 500, based on its sales records.
Controversies
On August 26, 2020, Bloomberg News implicated Avantor and other companies in the U.S. opioid epidemic. According to Bloomberg, one of their compounds "acetic anhydride", was used illicitly by drug traffickers to convert crude opium into heroin. Bloomberg also found evidence that Avantor's compound was used in cartel drug labs, and that regulations implemented in 2018 didn't stop it from being widely available. In response, Avantor discontinued all sales of acetic anhydride in Mexico and destroyed its existing inventory. In 2021, Texas Senator John Cornyn, who serves on both the Judiciary Committee and the bipartisan Caucus on International Narcotics Control claims that Avantor should have known better, selling acetic anhydride within Mexico's unregulated market. What should have raised eyebrows as well is that it was sold in 18-liter containers, which is inconsistent with the ordinary use of acetic anhydride. Four other Republican senators also deplored Avantor's “apparent longstanding contribution to the opioid epidemic that killed 50,000 of our fellow citizens in 2019.”
来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
AVTR 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
AVTR 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
财务健康 债务、流动性、偿付能力 — 资产负债表强度
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
资本效率 资产周转率、库存周转率、应收账款周转率
AVTR 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
- 强烈买入 3 12.0%
- 买入 5 20.0%
- 持有 16 64.0%
- 卖出 1 4.0%
- 强烈卖出 0 0.0%
12个月价格目标
14 位分析师 · 2026-08-17收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $0.21 | $0.19 | 0.02% |
| 2026年3月31日 | $0.17 | $0.16 | 0.01% |
| 2025年12月31日 | $0.22 | $0.22 | -0.00% |
| 2025年9月30日 | $0.22 | $0.23 | -0.01% |
| 2025年6月30日 | $0.24 | $0.25 | -0.01% |
| 2025年3月31日 | $0.23 | $0.24 | -0.01% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| AVTR | $7.82B | -14.7 | -3.4% | -8.1% | -8.9% | 32.6% |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | — |
| TECH | $7.97B | 111.8 | 5.2% | 6.0% | 3.7% | 64.8% |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | — |
| BIO | — | — | — | — | — | — |
| BRKR | $7.17B | -314.1 | 2.1% | -0.25% | -0.40% | 45.9% |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
| SHC | $5.02B | 65.3 | 5.7% | 6.7% | 14.0% | 55.5% |
| ADPT | $2.50B | -41.6 | 54.8% | -21.5% | -28.2% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B | $6.39B | $6.04B | $5.86B | $1.25B | |
| Cost of Revenue | $4.41B | $4.50B | $4.60B | $4.91B | $4.88B | $4.31B | $4.12B | $4.04B | $815M | |
| Gross Profit | $2.14B | $2.28B | $2.36B | $2.60B | $2.50B | $2.08B | $1.92B | $1.82B | $433M | |
| SG&A Expense | $1.60B | $1.64B | $1.51B | $1.47B | $1.53B | $1.37B | $1.37B | $1.41B | $450M | |
| Operating Income | $-246M | $1.08B | $696M | $1.13B | $972M | $707M | $552M | $414M | $-210M | |
| Interest Expense | · | · | $285M | $266M | $217M | $308M | $440M | $524M | $201M | |
| Interest Income | $42M | $75M | $65M | $16M | $2M | · | · | · | · | |
| Other Non-op | $-21M | $-1M | $6M | $-800.0K | $11M | $10M | $2M | $-4M | $8M | |
| Pretax Income | $-441M | $854M | $410M | $851M | $753M | $62M | $41M | $-114M | $-460M | |
| Income Tax | $89M | $142M | $89M | $165M | $180M | $-54M | $3M | $-27M | $-315M | |
| Net Income | $-530M | $712M | $321M | $686M | $573M | $117M | $38M | $-87M | $-113M | |
| EPS (Basic) | $-0.78 | $1.05 | $0.48 | $1.02 | $0.86 | $0.09 | $-0.84 | $-2.69 | · | |
| EPS (Diluted) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 | $0.09 | $-0.84 | $-2.69 | · | |
| Shares (Basic) | 680,600,000 | 679,600,000 | 675,600,000 | 650,900,000 | 590,500,000 | 576,300,000 | 401,200,000 | 132,700,000 | · | |
| Shares (Diluted) | 680,600,000 | 681,900,000 | 678,400,000 | 679,400,000 | 599,600,000 | 583,400,000 | 401,200,000 | 132,700,000 | · | |
| EBITDA | $-246M | $1.08B | $696M | $1.13B | $972M | $707M | $552M | · | · |
资产负债表 26
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $365M | $262M | $263M | $373M | $302M | $287M | $187M | $185M | · | |
| Receivables | $1.07B | $1.03B | $1.15B | $1.22B | $1.22B | $1.11B | $989M | $931M | · | |
| Inventory | $818M | $732M | $828M | $914M | $872M | $740M | $711M | $671M | · | |
| Other Current Assets | $193M | $119M | $144M | $153M | $81M | $91M | $135M | $113M | · | |
| Current Assets | $2.45B | $2.15B | $2.38B | $2.66B | $2.48B | $2.23B | $2.02B | $1.90B | · | |
| PP&E (Net) | $767M | $708M | $738M | $727M | $706M | $550M | $557M | $599M | · | |
| PP&E (Gross) | $1.51B | $1.34B | $1.35B | $1.25B | $1.15B | $938M | $865M | $824M | · | |
| Accum. Depreciation | $745M | $630M | $617M | $518M | $445M | $388M | $308M | $226M | · | |
| Goodwill | $4.99B | $5.54B | $5.72B | $5.65B | $5.34B | $2.86B | $2.77B | $2.78B | $2.85B | |
| Intangibles | $3.10B | $3.27B | $3.68B | $4.04B | $5.05B | $3.96B | $4.13B | $4.47B | · | |
| Other Non-current Assets | $396M | $360M | $358M | $294M | $233M | $217M | $205M | $63M | · | |
| Total Assets | $11.79B | $12.11B | $12.97B | $13.46B | $13.90B | $9.91B | $9.77B | $9.91B | · | |
| Accounts Payable | $742M | $663M | $626M | $758M | $755M | $679M | $560M | $557M | · | |
| Current Liabilities | $1.38B | $2.01B | $1.48B | $1.66B | $1.45B | $1.24B | $1.07B | $1.10B | · | |
| Capital Leases | $152M | $143M | $88M | $87M | $79M | · | $107M | · | · | |
| Deferred Tax | $557M | $557M | $613M | $731M | $913M | $724M | $785M | $908M | · | |
| Other Non-current Liabilities | $378M | $358M | $350M | $295M | $358M | $398M | $428M | $318M | · | |
| Total Liabilities | $6.23B | $6.16B | $7.72B | $8.61B | $9.70B | $7.23B | $7.31B | $9.10B | · | |
| Long-term Debt | $3.95B | $4.06B | $5.54B | $6.29B | $7.02B | $4.89B | $5.12B | $6.92B | · | |
| Total Debt | $3.95B | $4.06B | $5.54B | $6.29B | $7.02B | $4.89B | $5.12B | · | · | |
| Retained Earnings | $1.67B | $2.20B | $1.49B | $1.17B | $484M | $-89M | $-204M | $-238M | · | |
| Treasury Stock | $76M | $0 | · | · | · | · | · | · | · | |
| AOCI | $-17M | $-184M | $-69M | $-100M | $-43M | $22M | $-86M | $-66M | $26M | |
| Stockholders' Equity | $5.57B | $5.96B | $5.25B | $4.86B | $4.20B | $2.67B | $2.46B | $-3.05B | $-2.62B | |
| Liabilities + Equity | $11.79B | $12.11B | $12.97B | $13.46B | $13.90B | $9.91B | $9.77B | $9.91B | · | |
| Shares Outstanding | 682,000,000 | 680,800,000 | 676,600,000 | 674,300,000 | 609,700,000 | 580,100,000 | 572,800,000 | 132,800,000 | · |
现金流 18
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $410M | $406M | $402M | $406M | $379M | $395M | $399M | $405M | $99M | |
| Stock-based Comp | $46M | $47M | $40M | $46M | $51M | $44M | $68M | $18M | $48M | |
| Deferred Tax | $8M | $-47M | $-172M | $-69M | $-18M | $-88M | $-107M | $-104M | $-431M | |
| Amort. of Intangibles | $301M | $300M | $308M | $318M | $291M | $308M | $312M | $321M | $65M | |
| Restructuring | $30M | $83M | $26M | $4M | $5M | $12M | $24M | $81M | $30M | |
| Operating Cash Flow | $624M | $841M | $870M | $844M | $954M | $930M | $354M | $200M | $-168M | |
| CapEx | $129M | $149M | $146M | $133M | $111M | $62M | $52M | $38M | $25M | |
| Investing Cash Flow | $-130M | $439M | $-144M | $-110M | $-4.12B | $-59M | $-42M | $-23M | $-6.68B | |
| Debt Issued | $1.11B | $0 | $0 | $327M | $2.83B | $3.94B | $1M | $36M | $9.25B | |
| Net Debt Issued | $-319M | $-1.34B | $-846M | $-620M | $2.30B | $-423M | $-1.88B | · | · | |
| Stock Issued | · | · | $0 | $0 | $967M | $0 | $4.24B | · | · | |
| Stock Repurchased | $75M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $-75M | · | $0 | $0 | $967M | · | · | · | · | |
| Financing Cash Flow | $-409M | $-1.28B | $-844M | $-649M | $3.22B | $-783M | $-308M | $-170M | $6.96B | |
| Net Change in Cash | $104M | $-23M | $-109M | $70M | $38M | $100M | $2M | $-800.0K | $122M | |
| Taxes Paid | $145M | $248M | $224M | $257M | $145M | $43M | $112M | $66M | $32M | |
| Free Cash Flow | $495M | $692M | $724M | $710M | $842M | $868M | $302M | · | · | |
| Levered FCF | · | · | $501M | $496M | $677M | $292M | $-107M | · | · |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.6% | 33.6% | 33.9% | 34.6% | 33.9% | 32.5% | 31.8% | · | · | |
| Operating Margin | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% | 11.1% | 9.1% | · | · | |
| Net Margin | -8.1% | 10.5% | 4.6% | 9.1% | 7.8% | 1.8% | 0.63% | · | · | |
| Pretax Margin | -6.7% | 12.6% | 5.9% | 11.3% | 10.2% | 0.97% | 0.67% | · | · | |
| EBITDA Margin | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% | 11.1% | 9.1% | · | · | |
| ROA | -4.4% | 5.7% | 2.4% | 5.0% | 4.8% | 1.2% | 0.38% | · | · | |
| ROE | -8.9% | 12.4% | 6.2% | 14.5% | 13.8% | 4.5% | 1.6% | · | · | |
| ROIC | -3.1% | 9.0% | 5.1% | 8.2% | 6.6% | 17.5% | 6.8% | · | · |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.1 | 1.6 | 1.6 | 1.7 | 1.8 | 1.9 | · | · | |
| Quick Ratio | 1.0 | 0.6 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | · | · | |
| Debt / Equity | 0.7 | 0.7 | 1.1 | 1.3 | 1.7 | 1.8 | 2.1 | · | · | |
| LT Debt / Equity | 0.7 | 0.5 | 1.0 | 1.2 | 1.7 | 1.8 | 2.0 | · | · | |
| Interest Coverage | · | · | 2.4 | 4.3 | 4.5 | 2.3 | 1.3 | · | · |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | · | · | |
| Inventory Turnover | 5.7 | 5.8 | 5.3 | 5.5 | 6.1 | 5.9 | 6.0 | · | · | |
| Receivables Turnover | 6.2 | 6.2 | 5.9 | 6.2 | 6.3 | 6.1 | 6.3 | · | · |
增长率 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -3.4% | -2.6% | -7.3% | 1.7% | 15.5% | · | · | · | · | |
| Revenue CAGR 3Y | -4.5% | -2.8% | 2.9% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.49% | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 121.3% | -53.5% | 18.8% | 844.4% | · | · | · | · | |
| EPS CAGR 3Y | · | 7.0% | 73.5% | · | · | · | · | · | · | |
| Net Income YoY | · | 121.6% | -53.2% | 19.9% | 391.1% | · | · | · | · | |
| Net Income CAGR 3Y | · | 7.5% | 40.2% | · | · | · | · | · | · |
估值 (TTM) 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B | $6.39B | $6.04B | · | · | |
| Net Income TTM | $-530M | $712M | $321M | $686M | $573M | $117M | $38M | · | · | |
| Market Cap | $7.82B | $14.34B | $15.45B | $14.22B | $25.69B | $16.33B | $10.40B | · | · | |
| Enterprise Value | $11.40B | $18.14B | $20.72B | $20.14B | $32.41B | $20.94B | $15.33B | · | · | |
| P/E | -14.7 | 20.3 | 48.6 | 20.9 | 49.6 | 312.8 | -21.6 | · | · | |
| P/S | 1.2 | 2.1 | 2.2 | 1.9 | 3.5 | 2.6 | 1.7 | · | · | |
| P/B | 1.4 | 2.4 | 2.9 | 2.9 | 6.1 | 6.1 | 4.2 | · | · | |
| P / Cash Flow | 12.5 | 17.1 | 17.8 | 16.9 | 26.9 | 17.6 | 29.4 | · | · | |
| P / FCF | 15.8 | 20.7 | 21.3 | 20.0 | 30.5 | 18.8 | 34.4 | · | · | |
| EV / EBITDA | -46.3 | 16.7 | 29.8 | 17.8 | 33.3 | 29.6 | 27.8 | · | · | |
| EV / FCF | 23.0 | 26.2 | 28.6 | 28.4 | 38.5 | 24.1 | 50.7 | · | · | |
| EV / Revenue | 1.7 | 2.7 | 3.0 | 2.7 | 4.4 | 3.3 | 2.5 | · | · | |
| Earnings Yield | -6.8% | 4.9% | 2.1% | 4.8% | 2.0% | 0.32% | -4.6% | · | · |
损益表 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.69B | $1.58B | $1.66B | $1.62B | $1.68B | $1.58B | $1.69B | $1.71B | $1.70B | $1.68B | $1.72B | $1.72B | $1.74B | $1.78B | $1.79B | $1.86B | |
| Cost of Revenue | $1.16B | $1.08B | $1.14B | $1.10B | $1.13B | $1.05B | $1.12B | $1.15B | $1.12B | $1.11B | $1.15B | $1.14B | $1.15B | $1.16B | $1.18B | $1.21B | |
| Gross Profit | $537M | $501M | $524M | $526M | $554M | $535M | $563M | $564M | $582M | $570M | $570M | $579M | $590M | $625M | $614M | $651M | |
| SG&A Expense | $415M | $401M | $392M | $390M | $425M | $388M | $371M | $440M | $406M | $424M | $387M | $368M | $358M | $394M | $363M | $375M | |
| Operating Income | $122M | $100M | $126M | $-649M | $129M | $147M | $638M | $125M | $176M | $146M | $183M | $210M | $72M | $231M | $252M | $276M | |
| Interest Expense | $39M | $43M | · | $44M | $43M | $42M | · | $49M | $61M | $64M | · | $72M | $73M | $74M | · | $67M | |
| Interest Income | $10M | $10M | $11M | $12M | $11M | $8M | $12M | $27M | $18M | $18M | $18M | $17M | $16M | $14M | · | · | |
| Other Non-op | $-600.0K | $-500.0K | $-1M | $4M | $-4M | $-20M | $-5M | $700.0K | $2M | $1M | $2M | $700.0K | $2M | $600.0K | $-6M | $3M | |
| Pretax Income | $81M | $56M | $81M | $-690M | $82M | $86M | $584M | $74M | $115M | $81M | $120M | $136M | $-1M | $156M | $175M | $208M | |
| Income Tax | $43M | $12M | $28M | $22M | $17M | $21M | $84M | $17M | $22M | $20M | $21M | $28M | $6M | $34M | $33M | $41M | |
| Net Income | $38M | $43M | $52M | $-712M | $65M | $64M | $500M | $58M | $93M | $60M | $98M | $108M | $-7M | $122M | $142M | $167M | |
| EPS (Basic) | $0.06 | $0.06 | $0.08 | $-1.04 | $0.09 | $0.09 | $0.74 | $0.08 | $0.14 | $0.09 | $0.15 | $0.16 | $-0.01 | $0.18 | $0.20 | $0.25 | |
| EPS (Diluted) | $0.06 | $0.06 | $0.08 | $-1.04 | $0.09 | $0.09 | $0.73 | $0.08 | $0.14 | $0.09 | $0.14 | $0.16 | $-0.01 | $0.18 | $0.20 | $0.25 | |
| Shares (Basic) | 676,200,000 | 675,700,000 | -1,363,700,000 | 681,700,000 | 681,500,000 | 681,100,000 | -1,358,200,000 | 680,300,000 | 679,400,000 | 678,100,000 | -1,350,400,000 | 676,000,000 | 675,300,000 | 674,700,000 | -1,277,500,000 | 674,100,000 | |
| Shares (Diluted) | 677,200,000 | 676,800,000 | -1,365,300,000 | 681,700,000 | 681,800,000 | 682,400,000 | -1,365,100,000 | 683,000,000 | 682,600,000 | 681,400,000 | -1,353,500,000 | 678,500,000 | 675,300,000 | 678,100,000 | -1,361,400,000 | 679,300,000 | |
| EBITDA | $122M | $100M | · | $-649M | $129M | $147M | · | $125M | $176M | $146M | · | $210M | $72M | $231M | · | $276M |
资产负债表 26
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $307M | $279M | $365M | $252M | $449M | $316M | $262M | $285M | $273M | $235M | · | $237M | $236M | $295M | · | $266M | |
| Receivables | $1.14B | $1.10B | $1.07B | $1.08B | $1.15B | $1.10B | $1.03B | $1.09B | $1.13B | $1.13B | · | $1.15B | $1.22B | $1.28B | · | $1.23B | |
| Inventory | $829M | $810M | $818M | $796M | $780M | $750M | $732M | $780M | $796M | $811M | · | $850M | $890M | $904M | · | $905M | |
| Other Current Assets | $188M | $210M | $193M | $132M | $136M | $120M | $119M | $136M | $132M | $146M | · | $147M | $156M | $152M | · | $158M | |
| Current Assets | $2.46B | $2.40B | $2.45B | $2.26B | $2.51B | $2.28B | $2.15B | $2.50B | $2.33B | $2.32B | · | $2.38B | $2.50B | $2.63B | · | $2.56B | |
| PP&E (Net) | $772M | $766M | $767M | $762M | $759M | $736M | $708M | $723M | $754M | $740M | · | $698M | $698M | $736M | · | $698M | |
| PP&E (Gross) | · | · | $1.51B | · | · | · | $1.34B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $787M | $766M | $745M | $724M | $700M | $663M | $630M | $621M | $657M | $635M | · | $580M | $565M | $541M | · | $489M | |
| Goodwill | $4.94B | $4.95B | $4.99B | $4.98B | $5.76B | $5.61B | $5.54B | $5.67B | $5.66B | $5.67B | $5.72B | $5.64B | $5.69B | $5.68B | $5.65B | $5.51B | |
| Intangibles | $2.92B | $3.01B | $3.10B | $3.17B | $3.26B | $3.24B | $3.27B | $3.43B | $3.49B | $3.57B | · | $3.70B | $3.80B | $3.98B | · | $4.01B | |
| Other Non-current Assets | $412M | $442M | $396M | $406M | $391M | $368M | $360M | $420M | $368M | $368M | · | $289M | $277M | $272M | · | $245M | |
| Total Assets | $11.60B | $11.66B | $11.79B | $11.68B | $12.78B | $12.33B | $12.11B | $12.84B | $12.69B | $12.76B | · | $12.80B | $13.06B | $13.40B | · | $13.11B | |
| Accounts Payable | $743M | $736M | $742M | $692M | $709M | $680M | $663M | $674M | $657M | $573M | · | $656M | $687M | $766M | · | $769M | |
| Current Liabilities | $1.38B | $1.37B | $1.38B | $1.52B | $2.58B | $2.03B | $2.01B | $1.63B | $1.46B | $1.44B | · | $1.49B | $1.55B | $1.67B | · | $1.55B | |
| Capital Leases | · | · | $152M | · | · | · | $143M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $540M | $550M | $557M | $548M | $536M | $550M | $557M | $547M | $575M | $601M | · | $649M | $663M | $696M | · | $728M | |
| Other Non-current Liabilities | $383M | $377M | $378M | $403M | $391M | $365M | $358M | $419M | $362M | $361M | · | $271M | $269M | $300M | · | $334M | |
| Total Liabilities | $5.97B | $6.07B | $6.23B | $6.11B | $6.49B | $6.23B | $6.16B | $7.29B | $7.26B | $7.43B | · | $7.70B | $8.05B | $8.40B | · | $8.52B | |
| Long-term Debt | $3.70B | $3.82B | $3.95B | $3.86B | $4.24B | $4.11B | $4.06B | $4.92B | $5.12B | $5.32B | · | $5.63B | $5.88B | $6.06B | · | $6.19B | |
| Total Debt | $3.70B | $3.82B | · | $3.86B | $4.24B | $4.11B | · | $4.92B | $5.12B | $5.32B | · | $5.63B | $5.88B | $6.06B | · | $6.19B | |
| Retained Earnings | $1.75B | $1.72B | $1.67B | $1.62B | $2.33B | $2.27B | $2.20B | $1.70B | $1.64B | $1.55B | · | $1.39B | $1.28B | $1.29B | · | $1.03B | |
| Treasury Stock | $76M | $76M | $76M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $-55M | $-44M | $-17M | $-24M | $-10M | $-118M | $-184M | $-74M | $-107M | $-97M | · | $-111M | $-72M | $-90M | $-100M | $-212M | |
| Stockholders' Equity | $5.63B | $5.59B | $5.57B | $5.57B | $6.29B | $6.10B | $5.96B | $5.55B | $5.43B | $5.34B | $5.25B | $5.10B | $5.01B | $4.99B | $4.86B | $4.59B | |
| Liabilities + Equity | $11.60B | $11.66B | $11.79B | $11.68B | $12.78B | $12.33B | $12.11B | $12.84B | $12.69B | $12.76B | · | $12.80B | $13.06B | $13.40B | · | $13.11B | |
| Shares Outstanding | · | 682,900,000 | 682,000,000 | 681,900,000 | 681,600,000 | 681,500,000 | 680,800,000 | 680,600,000 | 679,600,000 | 679,200,000 | · | 676,300,000 | 675,700,000 | 675,100,000 | · | 674,200,000 |
现金流 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $106M | $105M | $103M | $104M | $103M | $100M | $101M | $102M | $103M | $100M | $101M | $98M | $103M | $101M | $101M | $101M | |
| Stock-based Comp | $15M | $9M | $11M | $7M | $16M | $12M | $11M | $12M | $11M | $13M | $9M | $10M | $9M | $13M | $10M | $12M | |
| Deferred Tax | $16M | $-10M | $50M | $-12M | $-18M | $-12M | $28M | $-23M | $-35M | $-18M | $-78M | $-29M | $-38M | $-26M | $-7M | $-22M | |
| Restructuring | · | · | $2M | $2M | · | · | $500.0K | $49M | · | · | $8M | $6M | $7M | $5M | $-200.0K | $1M | |
| Operating Cash Flow | $178M | $59M | $153M | $207M | $154M | $109M | $173M | $245M | $281M | $142M | $252M | $231M | $168M | $220M | $206M | $258M | |
| CapEx | $38M | $34M | $36M | $36M | $30M | $28M | $28M | $41M | $46M | $35M | $51M | $38M | $30M | $28M | $34M | $39M | |
| Investing Cash Flow | $-37M | $-33M | $-40M | $-33M | $-29M | $-29M | $558M | $-40M | $-45M | $-34M | $-50M | $-37M | $-29M | $-27M | $-33M | $4M | |
| Debt Issued | · | · | $1.04B | $68M | $0 | $0 | $0 | $-12M | $-29M | $41M | $0 | $0 | $0 | $0 | $82M | $35M | |
| Net Debt Issued | · | $-105M | · | · | · | $-31M | · | · | · | $-169M | · | · | · | $-270M | · | · | |
| Financing Cash Flow | $-112M | $-107M | $700.0K | $-370M | $-7M | $-34M | $-755M | $-199M | $-197M | $-130M | $-184M | $-188M | $-196M | $-275M | $-82M | $-219M | |
| Net Change in Cash | $28M | $-86M | $114M | $-198M | $134M | $54M | $-46M | $14M | $38M | $-28M | $27M | $-100.0K | $-58M | $-78M | $109M | $27M | |
| Taxes Paid | $30M | $10M | $29M | $22M | $77M | $17M | $120M | $42M | $69M | $17M | $29M | $69M | $113M | $14M | $75M | $51M | |
| Free Cash Flow | · | $25M | · | · | · | $81M | · | · | · | $107M | · | · | · | $192M | · | · | |
| Levered FCF | · | $-8M | · | · | · | $50M | · | · | · | $59M | · | · | · | $134M | · | · |
盈利能力 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.7% | 31.7% | · | 32.4% | 32.9% | 33.8% | · | 32.9% | 34.2% | 34.0% | · | 33.6% | 33.8% | 35.1% | · | 35.0% | |
| Operating Margin | 7.2% | 6.3% | · | -40.0% | 7.6% | 9.3% | · | 7.3% | 10.3% | 8.7% | · | 12.2% | 4.1% | 13.0% | · | 14.9% | |
| Net Margin | 2.2% | 2.7% | · | -43.8% | 3.8% | 4.1% | · | 3.4% | 5.5% | 3.6% | · | 6.3% | -0.42% | 6.8% | · | 9.0% | |
| Pretax Margin | 4.8% | 3.5% | · | -42.5% | 4.9% | 5.4% | · | 4.3% | 6.7% | 4.8% | · | 7.9% | -0.07% | 8.8% | · | 11.2% | |
| EBITDA Margin | 7.2% | 6.3% | · | -40.0% | 7.6% | 9.3% | · | 7.3% | 10.3% | 8.7% | · | 12.2% | 4.1% | 13.0% | · | 14.9% | |
| ROA | 0.31% | 0.36% | · | -5.8% | 0.51% | 0.51% | · | 0.45% | 0.72% | 0.46% | · | 0.84% | -0.06% | 0.89% | · | 1.3% | |
| ROE | 0.64% | 0.74% | · | -12.8% | 1.1% | 1.1% | · | 1.1% | 1.8% | 1.2% | · | 2.2% | -0.15% | 2.6% | · | 3.8% | |
| ROIC | 0.61% | 0.83% | · | -7.1% | 0.97% | 1.1% | · | 0.92% | 1.4% | 1.0% | · | 1.6% | 3.7% | 1.6% | · | 2.1% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.8 | · | 1.5 | 1.0 | 1.1 | · | 1.5 | 1.6 | 1.6 | · | 1.6 | 1.6 | 1.6 | · | 1.6 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.6 | 0.7 | · | 0.8 | 1.0 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.5 | 0.5 | · | 0.8 | 0.9 | 0.9 | · | 1.0 | 1.1 | 1.1 | · | 1.3 | |
| Interest Coverage | 3.1 | 2.3 | · | -14.7 | 3.0 | 3.5 | · | 2.6 | 2.9 | 2.3 | · | 2.9 | 1.0 | 3.1 | · | 4.1 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.4 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.5 |
估值 (TTM) 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.58B | $6.47B | · | $6.60B | $6.68B | $6.68B | · | $6.82B | $6.85B | $6.92B | · | $7.10B | $7.29B | $7.50B | · | $7.55B | |
| Net Income TTM | $-566M | $-539M | · | $-525M | $280M | $276M | · | $320M | $254M | $283M | · | $390M | $469M | $666M | · | $702M | |
| Market Cap | · | $5.35B | · | $8.51B | $9.17B | $11.05B | · | $17.61B | $14.41B | $17.37B | · | $14.26B | $13.88B | $14.27B | · | $13.21B | |
| Enterprise Value | · | $8.89B | · | $12.12B | $12.97B | $14.84B | · | $22.24B | $19.25B | $22.46B | · | $19.65B | $19.53B | $20.04B | · | $19.14B | |
| P/E | -11.9 | -9.8 | · | -16.0 | 33.6 | 40.5 | · | 55.0 | 55.8 | 60.9 | · | 36.3 | 29.3 | 21.4 | · | 18.7 | |
| P/S | · | 0.8 | · | 1.3 | 1.4 | 1.7 | · | 2.6 | 2.1 | 2.5 | · | 2.0 | 1.9 | 1.9 | · | 1.7 | |
| P/B | · | 1.0 | · | 1.5 | 1.5 | 1.8 | · | 3.2 | 2.7 | 3.3 | · | 2.8 | 2.8 | 2.9 | · | 2.9 | |
| P / Cash Flow | · | 91.2 | · | · | · | 101.1 | · | · | · | 122.6 | · | · | · | 65.0 | · | · | |
| P / FCF | · | 212.5 | · | · | · | 135.9 | · | · | · | 162.5 | · | · | · | 74.5 | · | · | |
| EV / EBITDA | · | 89.4 | · | -18.7 | 100.7 | 100.7 | · | 178.5 | 109.5 | 153.5 | · | 93.5 | 272.3 | 86.7 | · | 69.4 | |
| EV / FCF | · | 352.8 | · | · | · | 182.5 | · | · | · | 210.1 | · | · | · | 104.6 | · | · | |
| EV / Revenue | · | 1.4 | · | 1.8 | 1.9 | 2.2 | · | 3.3 | 2.8 | 3.2 | · | 2.8 | 2.7 | 2.7 | · | 2.5 | |
| Earnings Yield | -8.4% | -10.2% | · | -6.2% | 3.0% | 2.5% | · | 1.8% | 1.8% | 1.6% | · | 2.8% | 3.4% | 4.7% | · | 5.4% |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B |
| 毛利率 % | 32.6% | 33.6% | 33.9% | 34.6% | 33.9% |
| 营业利润率 % | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% |
| 净收入 | $-530M | $712M | $321M | $686M | $573M |
| 稀释后每股收益 (EPS) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.7 | 0.7 | 1.1 | 1.3 | 1.7 |
| 流动比率 | 1.8 | 1.1 | 1.6 | 1.6 | 1.7 |
| 速动比率 | 1.0 | 0.6 | 1.0 | 1.0 | 1.1 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $495M | $692M | $724M | $710M | $842M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 498 家申报者 · $4.9B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 104 (0 与上一季度对比) | 60 (-11 与上一季度对比) | 175 (+11 与上一季度对比) | 116 (-7 与上一季度对比) | -19.3M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
公司内部人士 22 位内幕人士 · 16 位高管 · 7 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Michael Stubblefield | President and CEO | 2019年5月21日 A | 1034150 | 0 | 0 | $0 |
| Thomas A Szlosek | EVP and CFO | 2019年5月21日 A | 185714 | 0 | 0 | $0 |
| Corey Walker | President, VWR Dist. & Servs. | 2026年6月21日 F | 384535 | 0 | 0 | $0 |
| Bjorn Hofman | EVP and COO | 2019年5月21日 A | 157143 | 0 | 0 | $0 |
| Brittany Hankamer | EVP, Chief HR Officer | 2026年8月14日 F | 248864 | 0 | 0 | $0 |
| Steven W Eck | SVP & Chief Accounting Officer | 2026年7月31日 F | 129593 | 0 | 0 | $0 |
| Claudius Sokenu | EVP, Chief Legal & Compliance | 2026年7月24日 F | 251228 | 0 | 0 | $0 |
| Frederic Vanderhaegen | EVP, Europe | 2019年5月21日 A | 157143 | 0 | 0 | $0 |
| Devashish Ohri | EVP, AMEA | 2019年5月21日 A | 157143 | 0 | 0 | $0 |
| Justin Miller | EVP, Gen. Counsel & Secretary | 2019年5月21日 A | 128571 | 0 | 0 | $0 |
| Eric Mcallister | EVP and Chief Human Resources Officer | 2019年5月21日 A | 199051 | 0 | 0 | $0 |
| Ashish Kulkarni | EVP and Chief Technology Officer | 2019年5月21日 A | 128571 | 0 | 0 | $0 |
| Gerard Brophy | EVP, Biopharma Production | 2019年5月21日 A | 157143 | 0 | 0 | $0 |
| James Bramwell | EVP, Strategic Partners | 2019年5月21日 A | 128571 | 0 | 0 | $0 |
| Michael Wondrasch | EVP & CIO | 2019年5月21日 A | 128571 | 0 | 0 | $0 |
| Christophe Couturier | EVP, Services, Strategy & Business Transformation | 2019年5月21日 A | 157143 | 0 | 0 | $0 |
| Jo Natauri | 董事 | 2021年7月12日 P | 557656 | 0 | 0 | $0 |
| Thomas Connolly | 董事 | 2020年6月18日 S | 72620082 | 0 | 0 | $0 |
| Christi Shaw | 董事 | 2019年5月21日 A | 14286 | 0 | 0 | $0 |
| Jonathan M Peacock | 董事 | 2019年5月21日 M | 142001 | 0 | 0 | $0 |
| Rakesh Sachdev | 董事 | 2019年5月21日 A | 14286 | 0 | 0 | $0 |
| Rajiv Gupta | 董事 | 2019年5月21日 M | 843791 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| The Goldman Sachs Group, Inc., Goldman Sachs & Co. LLC, Broad Street Principal Investments, L.L.C., Bridge Street Opportunity Advisors, L.L.C., StoneBridge 2017, L.P., StoneBridge 2017 Offshore, L.P., StoneBridge 2018, L.P., StoneBridge 2018 Offshore, L.P., VWR Partners, L.P. ×8 申报 | 2021年5月7日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 75 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| EPSB · Harbor ETF Trust | 0.57% | 3303 NS | 2026年4月30日 | N-PORT |
| MIDE · DBX ETF Trust | 0.25% | 919 NS | 2026年5月29日 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.25% | 2311704 NS | 2026年4月30日 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.22% | 86237 NS | 2026年4月30日 | N-PORT |
| PTMC · Pacer Funds Trust | 0.16% | 78367 NS | 2026年4月30日 | N-PORT |
| MVV · ProShares Trust | 0.13% | 23570 NS | 2026年5月31日 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.13% | 98467 NS | 2026年4月30日 | N-PORT |
| NUSC · Nushares ETF Trust | 0.12% | 191963 NS | 2026年4月30日 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.12% | 1846654 NS | 2026年5月31日 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.11% | 11295 NS | 2026年4月30日 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund ... | 0.11% | 274096 NS | 2026年4月30日 | N-PORT |
| UMDD · ProShares Trust | 0.09% | 3291 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.09% | 316237 NS | 2026年4月30日 | N-PORT |
| REVS · Columbia ETF Trust I | 0.08% | 28893 NS | 2026年4月30日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.08% | 1382792 NS | 2026年4月30日 | N-PORT |
| SMDX · Tidal Trust III | 0.08% | 11859 NS | 2026年4月30日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.06% | 1114744 NS | 2026年4月30日 | N-PORT |
| TILT · FlexShares Trust | 0.05% | 136752 NS | 2026年4月30日 | N-PORT |
| RECS · Columbia ETF Trust I | 0.04% | 290577 NS | 2026年4月30日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.03% | 26060 NS | 2026年5月31日 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0.03% | 701903 NS | 2026年5月31日 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.02% | 33794 NS | 2026年5月31日 | N-PORT |
| SCHV · SCHWAB STRATEGIC TRUST | 0.02% | 341367 NS | 2026年5月31日 | N-PORT |
| JSTC · Tidal Trust I | 0.02% | 7157 NS | 2026年5月31日 | N-PORT |
| GVUS · Goldman Sachs ETF Trust | 0.02% | 7944 NS | 2026年5月31日 | N-PORT |
| JUST · Goldman Sachs ETF Trust | 0.01% | 6157 NS | 2026年5月31日 | N-PORT |
| DEUS · DBX ETF Trust | 0.01% | 2681 NS | 2026年5月29日 | N-PORT |
| SCHX · SCHWAB STRATEGIC TRUST | 0.01% | 719099 NS | 2026年5月31日 | N-PORT |
| SCHK · SCHWAB STRATEGIC TRUST | 0.01% | 54749 NS | 2026年5月31日 | N-PORT |
| GUSA · Goldman Sachs ETF Trust II | 0.01% | 22543 NS | 2026年5月31日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.01% | 401205 NS | 2026年5月31日 | N-PORT |
| MSLC · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 25075 NS | 2026年5月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 2248 NS | 2026年4月30日 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.00% | 1349 NS | 2026年5月31日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 804 NS | 2026年5月31日 | N-PORT |
| EBI · RBB Fund Trust | 0.00% | 24 NS | 2026年5月31日 | N-PORT |
| CLSE · Trust for Professional Managers | -0.07% | -45559 NS | 2026年5月31日 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | -0.10% | -289720 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VB · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VBR · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VFVA · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | — | — | 2026年7月15日 | 每日 |
| IVOO · VANGUARD ADMIRAL FUNDS | — | — | 2026年7月15日 | 每日 |
| IVOV · VANGUARD ADMIRAL FUNDS | — | — | 2026年7月15日 | 每日 |
| VONE · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VONV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| IJH · iShares Trust | — | — | 2026年8月18日 | 每日 |